Brind.
  1. Major pharmaceutical companies including Sanofi, Regeneron, Roche, Eli Lilly, Biogen, and Gilead are maintaining alliances and competing across key therapeutic areas like ophthalmology, immunology, and oncology.

Organon acquired U.S. rights to TOFIDENCE from Biogen and laid off employees at its Jersey City headquarters.

1 report, 1 independent Updated Jul 22
AI-generated analysis. Brind wrote this summary from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.

What happened

Some supportReported by 1 outlet

Organon acquired U.S. rights to TOFIDENCE from Biogen and laid off employees at its Jersey City headquarters.

Who's involved

What this event is mainly about
Organon & Co.Biogen

Keep exploring

Part of

Major pharmaceutical companies including Sanofi, Regeneron, Roche, Eli Lilly, Biogen, and Gilead are maintaining alliances and competing across key therapeutic areas like ophthalmology, immunology, and oncology.

Also in this story

All 12 developments

The entities involved

  • Organon & Co.

    pharmaceutical company

    Nothing else this week.

  • Biogen

    American multinational biotechnology company

    Nothing else this week.

Related events

Coverage

Newest first; wire copies grouped
  • Insider MonkeyOrganon & Co. (OGN) Restructures, Expands in Women’s Health and Biosimilars We recently published 10 Most Undervalued Pharma Stocks To Buy Now. Organon & Co stands tenth on our list and has expanded